Schizophrenia News and Research

Latest Schizophrenia News and Research

Visual cortex uses information gleaned from ears as well as eyes

Scientists studying brain process involved in sight have found the visual cortex also uses information gleaned from the ears as well as the eyes when viewing the world.

26 May 2014

Hallucinations common suicide motive in schizophrenia patients

Hallucinations and/or delusions appear to be a common factor prompting patients with schizophrenia to attempt suicide, say researchers.

23 May 2014

Study examines potential use of medical marijuana, CBD in treating epilepsy

The therapeutic potential of medical marijuana and pure cannabidiol (CBD), an active substance in the cannabis plant, for neurologic conditions is highly debated.

23 May 2014

Can cannabis help curb convulsions?

Experts say that vigorous investigations are needed to determine whether or not the medical use of marijuana would be of benefit to patients with epilepsy.

22 May 2014

Group of 11 genes could help predict alcoholism risk

A group of 11 genes can successfully predict whether an individual is at increased risk of alcoholism, a research team from the United States and Germany reported Tuesday.

22 May 2014

Little efficacy difference between old and new antipsychotics

Older and second-generation long-acting antipsychotics have broadly similar clinical efficacy, shows a randomised trial in JAMA.

21 May 2014

Hippocampal role in psychosis bolstered

Reduced hippocampal volumes exist in patients across the psychosis spectrum, shows the latest report from the B-SNIP study.

21 May 2014

New optical approach to brain scanning for patients with electronic implants

Scientists have advanced a brain-scanning technology that tracks what the brain is doing by shining dozens of tiny LED lights on the head. This new generation of neuroimaging compares favorably to other approaches but avoids the radiation exposure and bulky magnets the others require, according to new research at Washington University School of Medicine in St. Louis.

20 May 2014

Biomarker predicts stress reaction in schizophrenia patients

Salivary levels of the endogenous neuromodulator kynurenic acid can identify patients with schizophrenia who are intolerant of stress, research shows.

19 May 2014

Study: Premature babies' risk of brain injury influenced by genes

Premature babies' risk of brain injury is influenced by their genes, a new study suggests.

19 May 2014

Antipsychotic use linked to reduced patient violence

Prescribing antipsychotics may reduce psychiatric patients’ propensity to commit violent crime, a study in The Lancet suggests.

14 May 2014

Retrophin reports net loss of $70.6 million for first quarter 2014

Retrophin, Inc. today reported its financial results for the quarter ended March 31, 2014.

14 May 2014

Mylan releases generic version of Zyprexa Zydis Tablets

Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets.

14 May 2014

Salk scientists explore earliest detectable changes in the brain that lead to schizophrenia

Using new stem cell technology, scientists at the Salk Institute have shown that neurons generated from the skin cells of people with schizophrenia behave strangely in early developmental stages, providing a hint as to ways to detect and potentially treat the disease early.

14 May 2014

GE Healthcare, Tesla Engineering announce collaboration to develop ultra high-field MRI systems

Today at the joint meeting of the International Society for Magnetic Resonance in Medicine and the European Society for Magnetic Resonance in Medicine and Biology, GE Healthcare and Tesla Engineering Ltd. announced that they will collaborate together to produce 7.0 tesla (7.0T) human whole-body magnetic resonance imaging (MRI) scanners, and build upon the ten year history of GE innovations in this advanced, technical field.

12 May 2014

Antipsychotic medication can reduce violent crime among people with psychiatric illness

New data indicate that people with psychiatric illness are almost half as likely to commit a violent crime when taking antipsychotic medication (such as clozapine or risperidone) compared with when they are not using such medication. The reduction in violent crime was smaller with use of mood stabilising drugs (such as lithium or carbamazepine) and only apparent among male patients with bipolar disorder.

9 May 2014

Antipsychotic medication reduces violent crime rates

People who use antipsychotic medication (such as clozapine or risperidone) to treat psychiatric illness are nearly half as likely to commit a violent crime compared to when they are not using such medication, according to new results published in The Lancet.

8 May 2014